Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore additional resources to study natural toxins, pollutants including PFAS and 6-PPD-Q, and their biological effects.
ENVIRONMENTAL TOXICOLOGY TOOLS & SERVICESPHA-408 is an inhibitor of IκB kinase β (IKKβ; IC50 = 0.04 µM).1 It is selective for IKKβ over IKKα, Pim-1, Pim-2, Tie2, TrkA, and p70S6K (IC50s = 0.6-28.4 µM), as well as a panel of 26 kinases (IC50s = >30 µM for all). PHA-408 inhibits IL-1β-induced production of prostaglandin E2 (PGE2; Item No. 14010) in synovial fibroblasts isolated from patients with rheumatoid arthritis (IC50 = ~0.6 µM). In vivo, PHA-408 (50 mg/kg) reduces serum LPS-induced TNF-α production in rats. It inhibits joint swelling and bone destruction in a rat model of streptococcal cell wall-induced arthritis when administered at a dose of 10 mg/kg. PHA-408 (15 and 45 mg/kg) inhibits LPS- or cigarette smoke-induced bronchoalveolar lavage fluid (BALF) neutrophil influx and reduces BALF levels of IL-6, TNF-α, and IL-1β in rats.2
WARNING This product is not for human or veterinary use.
1. A novel, highly selective, tight binding IκB kinase-
2. Anti-